Global Drug Delivery Market to Observe Significant Growth as Chronic Diseases Record Increasing Numbers
Browse 83 market data Tables and 120 Figures spread over 336 Pages, along with in-depth analysis on Global Drug Delivery Market by Route of Administration, End-User, & by Geography.
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market by assessing major geographies and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis, with inputs derived from industry professionals across the value chain.
Global Drug Delivery Market Scenario
Drug delivery technologies change the profile of drug releases, such as distribution, absorption, as well as elimination for improving product safety and efficiency. Moreover, the most common routes of administration are oral, inhalation, enteral, parenteral, transdermal patches, and topical routes.
Over the last few decades, research and development (R&D) in the avenue of drug delivery devices has continued to augment across the world on account of the rising prevalence of chronic diseases. As per the Centers for Disease Control and Prevention (CDC), approximately 6 in 10 people in the United States suffered from at least one chronic disease in 2019, and 4 in 10 people had two or more chronic conditions. Furthermore, the American Cancer Society (ACS) evaluated that nearly 1,735,350 new cancer cases were diagnosed in 2018. Hence, the increasing rates of chronic conditions are set to play a vital role in fueling the global drug delivery market’s growth.
The Global Drug Delivery Market report provides data tables and includes charts and graphs for visual analysis.
Request Free Sample Report for Global Drug Delivery Market by End-User, Route of Administration, & by Geography: https://www.inkwoodresearch.com/reports/drug-delivery-market/#request-free-sample
Market by End-User
• Ambulatory Surgical Centers
• Home Care Settings
• Other End-Users
Market by Route of Administration
• Pulmonary Drug Delivery
• Nasal Drug Delivery
o Nasal Gels
o Nasal Powders
o Nasal Sprays
o Nasal Drops
• Injectable Drug Delivery
• Ocular Drug Delivery
• Implantable Drug Delivery
o Active Implantable Drug Delivery
o Passive Implantable Drug Delivery
• Topical Drug Delivery
• Transmucosal Drug Delivery
o Oral Transmucosal Drug Delivery
o Other Transmucosal Drug Delivery
• Oral Drug Delivery
o Solid Oral Drugs
o Semi-Solid Oral Drugs
o Liquid Oral Drugs
- The report provides a detailed analysis of the current and future market trends to identify the investment opportunities
- Market forecasts till 2030, using estimated market values as the base numbers
- Key market trends across the business segments, regions and countries
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2030
• TERUMO MEDICAL CORPORATION (MICROVENTION INC)
• KINDEVA DRUG DELIVERY (FORMERLY 3M DRUG DELIVERY SYSTEMS)
• NOVARTIS AG
• BAUSCH HEALTH COMPANIES INC (FORMERLY VALEANT PHARMACEUTICALS)
• NOVO NORDISK A/S
• BECTON, DICKINSON AND COMPANY (BD)
• BAXTER INTERNATIONAL INC
• BOEHRINGER INGELHEIM INTERNATIONAL GMBH
• ANTARES PHARMA INC
• GLAXOSMITHKLINE PLC
• JOHNSON & JOHNSON
• BAYER AG
• ALKERMES PLC
• BOSTON SCIENTIFIC CORPORATION
GLOBAL INJECTABLE DRUG DELIVERY MARKET - The global injectable drug delivery market is set to rise with a CAGR of 8.73% during the forecasted years of 2019 and 2027.
GLOBAL BIOMATERIALS MARKET - The global biomaterials market is projected to record a CAGR of 13.45% from 2021 and 2028.
GLOBAL PULMONARY DRUG DELIVERY MARKET - The global pulmonary drug delivery market is estimated to record a CAGR of 5.06% between the years 2019 to 2028.
GLOBAL DRUG DISCOVERY DELIVERY MARKET - Global machine learning market is evaluated to generate revenue of $22.08 billion by 2027, growing at a CAGR of 32.21% from 2019 to 2027.
169, Harrison Avenue
Boston, MA 02111
Tel: 1-(857) 293-0150
We at Inkwood research provide you with not just consulting services but also with syndicated and customized research reports which help advance your business further.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Drug Delivery Market to Observe Significant Growth as Chronic Diseases Record Increasing Numbers here
News-ID: 2531062 • Views: 190
More Releases from Inkwood Research
Rise in Demand for Modified Epoxy Resins Facilitates the Global Epoxy Resins Mar …
According to a new market research report launched by Inkwood Research, the Global Epoxy Resins Market is set to rise with a CAGR of 5.65% from 2022 to 2030 and is expected to generate a revenue of $12.43 billion by 2030. Browse 55 Market Data Tables and 47 Figures spread over 237 Pages, along with in-depth analysis on the Global Epoxy Resins Market by Raw Material, Component, Application & by Geography.
Rising Direct-to-Consumer Testing favorable to Global Genetic Testing Market Gro …
According to a new market research report launched by Inkwood Research, the Global Genetic Testing Market is predicted to garner $27.81 billion by 2030, projecting a CAGR of 10.25% during the forecast period, 2022-2030. Browse 72 Market Data Tables and 50 Figures spread over 260 Pages, along with in-depth analysis on the Global Genetic Testing Market by Type, Technology, Application, Disease, & by Geography. This insightful market research report by Inkwood
Growing Animal Population and Diseases favourable to Global Veterinary Vaccines …
As per a new market research report launched by Inkwood Research, the Global Veterinary Vaccines Market is set to garner $13.95 billion by 2030, growing with a CAGR of 7.37% over the forecasted years. Browse 78 market data Tables and 58 Figures spread over 200 Pages, along with in-depth analysis on Global Veterinary Vaccines Market by Animal Type, Product Type, Disease Type, and by Geography This insightful market research report by Inkwood
Wide Variety of Surgical Sutures Vital for the Global Surgical Sutures Market Gr …
As per a new market research report launched by Inkwood Research, the Global Surgical Sutures Market is expected to reach $5621.94 billion by 2030, growing with a CAGR of 5.46% over the forecasted years. Browse 78 market data Tables and 59 Figures spread over 247 Pages, along with in-depth analysis on Global Surgical Sutures Market by Product, Application, Type, and by Geography This insightful market research report by Inkwood Research focuses on
More Releases for Drug
Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: email@example.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: firstname.lastname@example.org or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning